The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with ...

A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the ...

The Florida surgeon general in January called for a halt in the use of covid mRNA vaccines. And in Texas, Attorney General ...

Melanoma Companies are involved in targeted therapeutics development with respective active and inactive (dormant or ...

Moderna (NASDAQ:MRNA) is targeting market approval of a personalized vaccine the company is developing with Merck (NYSE:MRK) ...

Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

Cash and cash equivalents at the end of fourth quarter of 2024 of approximately $60.0 million; secured up to €57.5 million in debt financing from the European Investment Bank (EIB); the company ...

A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney ...

Songwriter and music teacher Steve Young of Stevenage, Hertfordshire, made global news as one of the first people to be given ...

Fewer precancerous lesions are being found in young women undergoing cervical cancer screenings thanks to the human ...